109 related articles for article (PubMed ID: 6920299)
1. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
3. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
Weiler JM; Gleich GJ
J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of the binding and activation of the first component of human complement. The effect of synthetic peptides, immunoglobulin fragments and various proteins].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Levkovskiĭ AV
Biokhimiia; 1986 May; 51(5):707-18. PubMed ID: 3486677
[TBL] [Abstract][Full Text] [Related]
6. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
7. The activation of the alternative pathway C3 convertase by human plasma kallikrein.
DiScipio RG
Immunology; 1982 Mar; 45(3):587-95. PubMed ID: 6916710
[TBL] [Abstract][Full Text] [Related]
8. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
Sundsmo JS; Wood LM
J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
[TBL] [Abstract][Full Text] [Related]
9. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the alternative complement pathway and proteases of the coagulation system.
Kazatchkine MD; Jouvin MH
Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
[No Abstract] [Full Text] [Related]
12. Activation of the alternative pathway of human complement by haemoglobin.
Wilson WA; Thomas EJ
Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
[TBL] [Abstract][Full Text] [Related]
13. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
Isenman DE; Podack ER; Cooper NR
J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the initial C3 convertase of the alternative pathway of human complement.
Fishelson Z; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1430-4. PubMed ID: 6559201
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone inhibits the alternative and amplification pathways of complement.
Weiler JM; Packard BD
Infect Immun; 1982 Oct; 38(1):122-6. PubMed ID: 6754609
[TBL] [Abstract][Full Text] [Related]
16. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the mechanisms of anti-complement activity in Ixodes ricinus ticks.
Lawrie CH; Sim RB; Nuttall PA
Mol Immunol; 2005 Jan; 42(1):31-8. PubMed ID: 15488941
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the formation of the human amplification C3 convertase of complement by polycations.
Maillet F; Kazatchkine MD
Immunology; 1983 Sep; 50(1):27-33. PubMed ID: 6554235
[TBL] [Abstract][Full Text] [Related]
19. New synthetic inhibitor to the alternative complement pathway.
Ikari N; Sakai Y; Hitomi Y; Fujii S
Immunology; 1983 Aug; 49(4):685-91. PubMed ID: 6553561
[TBL] [Abstract][Full Text] [Related]
20. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]